These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8173712)

  • 1. An analysis of the cause of early mortality after administration of thrombolytic therapy. The Thrombolysis Angioplasty in Myocardial Infarction Study Group.
    Ohman EM; Topol EJ; Califf RM; Bates ER; Ellis SG; Kereiakes DJ; George BS; Samaha JK; Kline E; Sigmon KN
    Coron Artery Dis; 1993 Nov; 4(11):957-64. PubMed ID: 8173712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of combination thrombolytic therapy and timing of cardiac catheterization in acute myocardial infarction. Results of thrombolysis and angioplasty in myocardial infarction--phase 5 randomized trial. TAMI Study Group.
    Califf RM; Topol EJ; Stack RS; Ellis SG; George BS; Kereiakes DJ; Samaha JK; Worley SJ; Anderson JL; Harrelson-Woodlief L
    Circulation; 1991 May; 83(5):1543-56. PubMed ID: 1902405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombolytic therapy for women with myocardial infarction: is there a gender gap? Thrombolysis and Angioplasty in Myocardial Infarction Study Group.
    Lincoff AM; Califf RM; Ellis SG; Sigmon KN; Lee KL; Leimberger JD; Topol EJ
    J Am Coll Cardiol; 1993 Dec; 22(7):1780-7. PubMed ID: 8245328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gender and acute myocardial infarction: is there a different response to thrombolysis?
    Woodfield SL; Lundergan CF; Reiner JS; Thompson MA; Rohrbeck SC; Deychak Y; Smith JO; Burton JR; McCarthy WF; Califf RM; White HD; Weaver WD; Topol EJ; Ross AM
    J Am Coll Cardiol; 1997 Jan; 29(1):35-42. PubMed ID: 8996292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome of patients with diabetes mellitus and acute myocardial infarction treated with thrombolytic agents. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group.
    Granger CB; Califf RM; Young S; Candela R; Samaha J; Worley S; Kereiakes DJ; Topol EJ
    J Am Coll Cardiol; 1993 Mar; 21(4):920-5. PubMed ID: 8450161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group.
    Grines CL; Browne KF; Marco J; Rothbaum D; Stone GW; O'Keefe J; Overlie P; Donohue B; Chelliah N; Timmis GC
    N Engl J Med; 1993 Mar; 328(10):673-9. PubMed ID: 8433725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fate of patients with acute myocardial infarction with patency of the infarct-related vessel achieved with successful thrombolysis versus rescue angioplasty.
    Abbottsmith CW; Topol EJ; George BS; Stack RS; Kereiakes DJ; Candela RJ; Anderson LC; Harrelson-Woodlief SL; Califf RM
    J Am Coll Cardiol; 1990 Oct; 16(4):770-8. PubMed ID: 1698843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implications of recurrent ischemia after reperfusion therapy in acute myocardial infarction: a comparison of thrombolytic therapy and primary angioplasty.
    Stone GW; Grines CL; Browne KF; Marco J; Rothbaum D; O'Keefe J; Hartzler GO; Overlie P; Donohue B; Chelliah N
    J Am Coll Cardiol; 1995 Jul; 26(1):66-72. PubMed ID: 7797777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mortality within 24 hours of thrombolysis for myocardial infarction. The importance of early reperfusion. The GUSTO Investigators, Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.
    Kleiman NS; White HD; Ohman EM; Ross AM; Woodlief LH; Califf RM; Holmes DR; Bates E; Pfisterer M; Vahanian A
    Circulation; 1994 Dec; 90(6):2658-65. PubMed ID: 7994805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immediate coronary angioplasty versus intravenous streptokinase in acute myocardial infarction: left ventricular ejection fraction, hospital mortality and reinfarction.
    de Boer MJ; Hoorntje JC; Ottervanger JP; Reiffers S; Suryapranata H; Zijlstra F
    J Am Coll Cardiol; 1994 Apr; 23(5):1004-8. PubMed ID: 8144761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High dose bolus heparin as initial therapy before primary angioplasty for acute myocardial infarction: results of the Heparin in Early Patency (HEAP) pilot study.
    Verheugt FW; Liem A; Zijlstra F; Marsh RC; Veen G; Bronzwaer JG
    J Am Coll Cardiol; 1998 Feb; 31(2):289-93. PubMed ID: 9462569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of an aggressive invasive catheterization and revascularization strategy on mortality in patients with cardiogenic shock in the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries (GUSTO-I) trial. An observational study.
    Berger PB; Holmes DR; Stebbins AL; Bates ER; Califf RM; Topol EJ
    Circulation; 1997 Jul; 96(1):122-7. PubMed ID: 9236426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and angiographic outcomes in patients with previous coronary artery bypass graft surgery treated with primary balloon angioplasty for acute myocardial infarction. Second Primary Angioplasty in Myocardial Infarction Trial (PAMI-2) Investigators.
    Stone GW; Brodie BR; Griffin JJ; Grines L; Boura J; O'Neill WW; Grines CL
    J Am Coll Cardiol; 2000 Mar; 35(3):605-11. PubMed ID: 10716461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognosis in cardiogenic shock after acute myocardial infarction in the interventional era.
    Bengtson JR; Kaplan AJ; Pieper KS; Wildermann NM; Mark DB; Pryor DB; Phillips HR; Califf RM
    J Am Coll Cardiol; 1992 Dec; 20(7):1482-9. PubMed ID: 1452920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninvasive detection of reperfusion after thrombolysis based on serum creatine kinase MB changes and clinical variables. TAMI 7 Study Group. Thrombolysis and Angioplasty in Myocardial Infarction.
    Ohman EM; Christenson RH; Califf RM; George BS; Samaha JK; Kereiakes DJ; Worley SJ; Wall TC; Berrios E; Sigmon KN
    Am Heart J; 1993 Oct; 126(4):819-26. PubMed ID: 8213437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Timing, mode, and predictors of death after direct angioplasty for acute myocardial infarction.
    Krikorian RK; Vacek JL; Beauchamp GD
    Cathet Cardiovasc Diagn; 1995 Jul; 35(3):192-6. PubMed ID: 7553819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous transluminal coronary angioplasty for acute myocardial infarction.
    Rothbaum DA; Hodes ZI; Linnemeier TJ; Landin RJ; Ball MW
    Cardiol Clin; 1989 Nov; 7(4):837-51. PubMed ID: 2688885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical importance of thrombocytopenia occurring in the hospital phase after administration of thrombolytic therapy for acute myocardial infarction. The Thrombolysis and Angioplasty in Myocardial Infarction Study Group.
    Harrington RA; Sane DC; Califf RM; Sigmon KN; Abbottsmith CW; Candela RJ; Lee KL; Topol EJ
    J Am Coll Cardiol; 1994 Mar; 23(4):891-8. PubMed ID: 8106694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical experience with primary percutaneous transluminal coronary angioplasty compared with alteplase (recombinant tissue-type plasminogen activator) in patients with acute myocardial infarction: a report from the Second National Registry of Myocardial Infarction (NRMI-2).
    Tiefenbrunn AJ; Chandra NC; French WJ; Gore JM; Rogers WJ
    J Am Coll Cardiol; 1998 May; 31(6):1240-5. PubMed ID: 9581714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapy of cardiogenic shock in acute myocardial infarct].
    Görge G; Haude M; Baumgart D; Sack S; Ge J; Leischik R; Erbel R
    Herz; 1994 Dec; 19(6):360-70. PubMed ID: 7843692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.